Loading...

XCUR EXICURE INC Capital Structure Changes 8-K Filing

XCR

XCR

EXICURE INC

(XCUR)

2025 8-K

Bond Redemption

Quarterly Results Announced

Financial Statements

Convertible Bonds

Financial Results

Management Changes

Stock Sale & Lease

Filing Amendment

Acquisition Agreement

Management Changes

Nasdaq Compliance

Filing Amendment

Equity Compliance Update

Stock Purchase Agreement

Nasdaq Extension

Stock Purchase Agreement

Nasdaq Extension

Debt-Equity Exchange

Stock Split Announcement

Special Meeting Update

Stockholder Meeting

Quarterly Results

Nasdaq Listing Notice

Annual Meeting of Stockholders

Earnings Reports

Financial Results and Loan

Delisting Notice

Earnings Report

Licensing of Patents

Restatement of Financial St...

Departure of Directors and ...

Earnings Report

Departure of Matthias Schroff

Changes in Registrant's Cer...

Departure and Appointment o...

Regulation FD Disclosure

Agreement with Cyworld Z

Entry into Material Agreement

Regulation FD Disclosure

Departure of Directors and ...

Management Changes

Earnings Reports

Changes in Control of Regis...

Compliance Notice and Board...

Private Placement

Resignation of Director

External Links:

On November 10, 2025, Exicure, Inc. redeemed $3.125 million of its 2.90% Convertible Bonds due 2028 to streamline its finances. This was funded through internal cash and aims to enhance liquidity for the company's biotech operations.

AI Assistant

EXICURE INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.